N-Formyl-Methionyl-Leucyl-Phenylalanine Plays a Neuroprotective and Anticonvulsant Role in Status Epilepticus Model

Cell Mol Neurobiol. 2023 Nov;43(8):4231-4244. doi: 10.1007/s10571-023-01410-z. Epub 2023 Sep 24.

Abstract

Status epilepticus (SE) is described as continuous and self-sustaining seizures, which triggers hippocampal neurodegeneration, inflammation, and gliosis. N-formyl peptide receptor (FPR) has been associated with inflammatory process. N-formyl-methionyl-leucyl-phenylalanine (fMLP) peptide plays an anti-inflammatory role, mediated by the activation of G-protein-coupled FPR. Here, we evaluated the influence of fMLP peptides on the behavior of limbic seizures, memory consolidation, and hippocampal neurodegeneration process. Male Wistar rats (Rattus norvegicus) received microinjections of pilocarpine in hippocampus (H-PILO, 1.2 mg/μL, 1 μL) followed by fMLP (1 mg/mL, 1 μL) or vehicle (VEH, saline 0.9%, 1 μL). During the 90 min of SE, epileptic seizures were analyzed according to the Racine's Scale. After 24 h of SE, memory impairment was assessed by the inhibitory avoidance test and the neurodegeneration process was evaluated in hippocampal areas. There was no change in latency and number of wet dog shake (WDS) after administration of fMLP. However, our results showed that the intrahippocampal infusion of fMLP reduced the severity of seizures, as well as the number of limbic seizures. In addition, fMLP infusion protected memory dysfunction followed by SE. Finally, the intrahippocampal administration of fMLP attenuated the process of neurodegeneration in both hippocampi. Taken together, our data suggest a new insight into the functional role of fMLP peptides, with important implications for their potential use as a therapeutic agent for the treatment of brain disorders, such as epilepsy. Schematic drawing on the neuroprotective and anticonvulsant role of fMLP during status epilepticus. Initially, a cannula was implanted in hippocampus and pilocarpine/saline was administered into the hippocampus followed by fMLP/saline (A-C). fMLP reduced seizure severity and neuronal death in the hippocampus, as well as protecting against memory deficit (D).

Keywords: Epilepsy; Hippocampus; N-Formyl peptide receptor; N-Formyl-methionyl-leucyl-phenylalanine; Neuronal death; Status epilepticus.

MeSH terms

  • Animals
  • Anticonvulsants / pharmacology
  • Anticonvulsants / therapeutic use
  • Epilepsy* / drug therapy
  • Male
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • N-Formylmethionine Leucyl-Phenylalanine / therapeutic use
  • Peptides / therapeutic use
  • Pilocarpine / therapeutic use
  • Rats
  • Rats, Wistar
  • Seizures / drug therapy
  • Status Epilepticus* / complications
  • Status Epilepticus* / drug therapy

Substances

  • Anticonvulsants
  • N-Formylmethionine Leucyl-Phenylalanine
  • Pilocarpine
  • Peptides